NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $624,000 | +145.7% | 26,599 | +28.3% | 0.02% | +183.3% |
| Q4 2016 | $254,000 | -40.2% | 20,729 | -16.2% | 0.01% | -40.0% |
| Q3 2016 | $425,000 | +11.5% | 24,723 | -7.5% | 0.01% | +25.0% |
| Q2 2016 | $381,000 | +95.4% | 26,741 | +130.7% | 0.01% | +166.7% |
| Q4 2015 | $195,000 | -18.8% | 11,593 | -39.6% | 0.00% | -25.0% |
| Q2 2015 | $240,000 | +71.4% | 19,207 | +51.3% | 0.00% | +33.3% |
| Q1 2015 | $140,000 | -68.0% | 12,692 | -65.0% | 0.00% | -62.5% |
| Q3 2014 | $437,000 | +30.1% | 36,234 | +38.2% | 0.01% | +60.0% |
| Q2 2014 | $336,000 | +116.8% | 26,214 | +105.4% | 0.01% | +150.0% |
| Q1 2014 | $155,000 | -61.6% | 12,762 | -67.0% | 0.00% | -60.0% |
| Q3 2013 | $404,000 | – | 38,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |